Healthy Weight and Obesity Prevention: What Patients Need to Know

Table of Contents

• Key Points
• Background: Why This Research Matters
• What Is a “Healthy Weight”?
• How Excess Weight Harms the Heart: The Science Explained
• Beyond the Heart: Sleep Apnea and Behavioral Consequences
• Metabolically Healthy Obesity and the Obesity Paradox
• Mechanistic Triggering Factors: Why Do We Gain Weight?
• Prevention and Treatment: Lifestyle to Medication to Surgery
• The Role of Healthcare Providers and Health Promotion
• Limitations and Controversies
• Practical Recommendations for Patients
• Frequently Asked Questions
• Source Information

Key Points

• Nearly 74% of U.S. adults are overweight or obese, driving heart disease and heart failure.
• Obesity increases blood volume and enlarges the heart, causing structural and hormonal changes.
• Waist circumference and fitness matter beyond BMI for assessing weight-related heart risk.
• Metabolically healthy obesity and the obesity paradox are controversial; they do not prove obesity is safe.
• Prevention requires lifestyle changes, community action, and healthcare system shifts, not weight loss alone.

Background: Why This Research Matters

Overweight and obesity have reached epidemic levels in the United States and around the world. The authors of this review, published in the Journal of the American College of Cardiology, start with a startling fact: nearly three-fourths of U.S. adults are now overweight or obese.

In 2016, the prevalence of obesity—defined as a body mass index (BMI) of 30 kg/m² or higher—was 39.6% among U.S. adults. Even more concerning, 7.7% of adults had Class III obesity, which means a BMI of 40 kg/m² or higher (sometimes called "severe" or "extreme" obesity).

The economic impact is enormous. The authors report that obesity-related healthcare costs run from $147 billion to nearly $210 billion per year. Beyond medical bills, obesity also reduces job productivity, costing employers over $500 per obese worker per year.

Obesity is not just a cosmetic issue. It independently increases the risk of nearly all cardiovascular disease (CVD) risk factors, including high blood pressure (hypertension), abnormal cholesterol (dyslipidemia), blood sugar problems, metabolic syndrome, type 2 diabetes, and inflammation. It also increases the risk of heart attack, atrial fibrillation, and especially heart failure. This review is part of a series from the American College of Cardiology focusing on health promotion, and it provides a state-of-the-art look at how to prevent and manage unhealthy weight.

What Is a “Healthy Weight”?

The classic definition of normal weight is a BMI between 18.5 and 24.9 kg/m². But the authors emphasize that BMI is only one piece of the puzzle. A BMI of 30 or higher indicates obesity in U.S. Caucasians and African Americans. However, in Asian, Middle Eastern, and Mediterranean populations, a BMI of 25 or higher may already be considered obesity because of differences in body fat distribution and health risk.

Waist circumference (WC) and waist-to-hip ratio are also crucial. The authors give specific cutpoints:

• A waist circumference of 94 cm (about 37 inches) in men and 80 cm (about 31.5 inches) in women signals increased risk. For Asian, Middle Eastern, and Mediterranean populations, the corresponding cutpoints are 90 cm in men and 80 cm in women.
• Waist circumference values of 102 cm (about 40 inches) in men and 88 cm (about 34.6 inches) in women are particularly associated with increased risk of chronic disease. For Asian, Middle Eastern, and Mediterranean populations, the corresponding values are 94 cm in men and 80 cm in women.
• Waist-to-hip ratio values associated with substantially increased risk are 0.9 or higher for men and 0.85 or higher for women.

At any given BMI, a high waist circumference or waist-to-hip ratio can further increase risk. The authors also point out that cardiorespiratory fitness (CRF)—how well your heart and lungs deliver oxygen during exercise—is a major factor that can modify risk, a topic we return to later.

How Excess Weight Harms the Heart: The Science Explained

This section of the review examines the complex ways obesity affects the heart's structure and function. The authors describe these changes as a "multifactorial process of adaptation and maladaptation to excess fat accumulation."

Hemodynamic Changes: A High-Output State

In people with obesity, the body works harder to support excess fat tissue. There is an increase in total blood volume and fat-free mass, while resistance in the blood vessels drops. These changes produce a **high cardiac output (CO) state**—meaning the heart pumps more blood per minute than normal. Because the heart rate changes little, this higher output is driven by a larger stroke volume (the amount of blood pumped with each beat).

This increased workload causes the left ventricle (the heart's main pumping chamber) to enlarge. The heart may develop a type of thickening called eccentric left ventricular hypertrophy (LVH), where the chamber dilates and the walls thicken. If the hypertrophy is adequate, it can reduce wall stress; if not, the heart wall stress remains high, leading eventually to systolic dysfunction (weak pumping).

Cardiac Structure and Function: Key Findings

The authors summarize the impact of obesity on hemodynamics and cardiac structure in a table. Key effects include:

• Hemodynamics: increased blood volume, increased stroke volume, increased arterial pressure, increased LV wall stress, and pulmonary artery hypertension.
• Cardiac structure: LV concentric remodeling (thickening without enlargement), LV hypertrophy (both eccentric and concentric), left atrial enlargement, and right ventricular hypertrophy.
• Cardiac function: LV diastolic dysfunction (stiff or slow-relaxing heart muscle), LV systolic dysfunction (weak pumping), and right ventricular failure.
• Neurohumoral and metabolic changes: insulin resistance with hyperinsulinemia, leptin insensitivity with hyperleptinemia, reduced adiponectin, sympathetic nervous system activation, activation of the renin-angiotensin-aldosterone system, overexpression of peroxisome proliferator-activated receptors, and inflammation (elevated C-reactive protein and tumor necrosis factor).
• Cellular changes: hypertrophy (enlargement of heart muscle cells), apoptosis (cell death), and fibrosis (scarring).

These changes are most pronounced in Class III obesity (BMI ≥40 kg/m²), but they also occur, to a lesser degree, in people with Class I (BMI 30.0–34.9) and Class II (BMI 35.0–39.9) obesity. Even children and adolescents can show these cardiac changes.

Eccentric vs. Concentric LVH: A “Dimorphic” Response

Although the classic model suggests eccentric LVH (enlargement with thinning) should predominate in obesity, studies now show that **concentric LVH or concentric remodeling** (thickening without much enlargement) is actually more common. The main reason is high blood pressure, which frequently coexists with obesity.

Dr. Messerli and colleagues described a "dimorphic cardiac adaptation" to obesity and hypertension—a hybrid form of LVH. In this form, the LV chamber is larger than what you see with pure concentric LVH but smaller than with eccentric LVH, while the wall is thicker than eccentric LVH but thinner than pure concentric LVH. The duration and severity of both obesity and hypertension matter. For example:

• Long-standing, poorly controlled hypertension plus mild obesity → more likely to produce **concentric LVH**.
• Severe obesity of long duration with mild or controlled hypertension → more likely to produce **eccentric LVH**.

Fat Distribution Matters

Where fat is stored also influences the heart. A study by Neeland et al. showed that central (visceral) obesity (fat around the organs) is more often linked to concentric LV remodeling or LVH, with lower cardiac output and higher systemic vascular resistance. In contrast, peripheral obesity (fat under the skin, especially in the hips and thighs) is associated with eccentric LVH, higher cardiac output, and lower vascular resistance.

Diastolic and Systolic Dysfunction

LV diastolic dysfunction (difficulty relaxing and filling) is seen in all classes of obesity. In severe obesity, the LV end-diastolic pressure (the pressure in the heart just before it pumps) is often elevated at rest and increases significantly with exercise. Even asymptomatic obese people can have reduced mitral annular velocities on tissue Doppler imaging, which is a sign of subclinical diastolic dysfunction.

LV systolic function, as measured by ejection fraction, is usually normal or even supranormal in uncomplicated obesity. However, long-standing severe obesity can cause systolic dysfunction, and subtle abnormalities can be detected by strain imaging even when the ejection fraction looks normal.

Neurohormonal and Metabolic Factors

Multiple chemical and hormonal changes help explain how obesity damages the heart:

• Insulin resistance and hyperinsulinemia: High insulin levels may promote LVH by binding to insulin-like growth factor-1 receptors in the heart muscle and by stimulating the sympathetic nervous system. In animal models, insulin resistance increases fatty acid uptake in the heart, creating a toxic buildup of ceramides and other fat intermediates.
• Renin-angiotensin-aldosterone system (RAAS) activation: Fat cells produce angiotensinogen and angiotensin-converting enzyme (ACE), which activate this system. Angiotensin II is a potent growth factor that promotes heart muscle hypertrophy; aldosterone stimulates fibrosis.
• Leptin resistance and hyperleptinemia: Elevated leptin levels can stimulate collagen synthesis and scar formation in the heart.
• Low adiponectin: This is normally a cardioprotective hormone; low levels impair its anti-fibrotic effects.
• Lipotoxicity: Fatty acids and triglycerides accumulate inside heart muscle cells, causing dysfunction and death. Increased myocardial triglyceride has been linked to LVH in humans and in genetically obese rats.
• Inflammation and oxidative stress: High levels of tumor necrosis factor-alpha, reactive oxygen species, and C-reactive protein are seen in adipose tissue and may contribute to cardiac remodeling, though the authors note that confirmatory human data are still lacking.

Beyond the Heart: Sleep Apnea and Behavioral Consequences

Obesity and sleep-disordered breathing often go hand in hand. The most common type is obstructive sleep apnea (OSA), characterized by repeated collapse of the throat (pharynx) during sleep. Obesity is the most potent demographic risk factor for developing and worsening OSA, and OSA itself can lead to adverse health consequences.

How common is OSA in obesity? The authors report:

• OSA prevalence is greater than 40% in people who are overweight but otherwise healthy.
• In people with severe obesity (BMI ≥40 kg/m²), OSA prevalence is nearly 50% to 98%.

Why does obesity raise OSA risk? Fat around the neck, chest, and upper airway narrows the airway. Central (visceral) obesity increases mechanical load on the upper airway, making it more collapsible and impairing the body's ability to compensate during sleep. This is why men—who tend to carry more central fat—develop OSA more often than women. Women's peripheral fat distribution may be protective.

Weight loss is the most important and effective component of "healthy living medicine" (HLM) for reversing obesity and its consequences, including sleep apnea. However, the authors caution that psychological disorders—such as weight stigma and the internalization of weight bias—are common in people with obesity and can interfere with long-term success of weight loss programs.

Metabolically Healthy Obesity and the Obesity Paradox

Two concepts generate intense debate in the medical world: metabolically healthy obesity (MHO) and the obesity paradox.

MHO refers to people who have obesity (BMI ≥30) but do not have metabolic abnormalities such as hypertension, dyslipidemia, insulin resistance, or diabetes. Some researchers argue that MHO is a lower-risk phenotype, while others believe it still carries excess cardiovascular risk compared to normal-weight metabolically healthy individuals. The authors note that this remains an area of considerable controversy.

The "obesity paradox" describes the observation that in some populations with established cardiovascular disease (especially heart failure and coronary heart disease), patients with overweight or obesity seem to have better survival than normal-weight patients. This does not mean obesity is protective; rather, it may reflect the fact that obesity provides greater metabolic reserve, or that normal-weight patients with heart disease are more likely to be frail or have other conditions. The review emphasizes that caution is needed when interpreting these observational findings.

Importantly, the authors highlight the role of cardiorespiratory fitness (CRF) as a major modifier. Fit individuals who are obese may have lower risk than unfit normal-weight individuals. This is why "healthy weight" cannot be defined by BMI alone—it must be considered alongside fitness and metabolic health.

Mechanistic Triggering Factors: Why Do We Gain Weight?

The authors discuss a range of factors that drive the obesity epidemic. These include (as listed in the Central Illustration):

• Dietary calories, refined carbohydrates, and added sugars: Excess calorie intake, particularly from highly processed foods and sugar-sweetened beverages (SSBs), is a primary driver.
• Physical activity and sedentary behaviors: Physical inactivity and prolonged sedentary time increase the risk of weight gain and cardiovascular disease independently.
• Genetics: There is a genetic predisposition to obesity, but genes do not change rapidly enough to explain the epidemic—they interact with an obesogenic environment.

The authors also point to the role of community and societal systems. Lack of safe places to be active, easy access to cheap, calorie-dense foods, and aggressive marketing of unhealthy products all contribute to weight gain. Personal choices happen in a broader context.

Prevention and Treatment: Lifestyle to Medication to Surgery

The review outlines a multi-tiered approach. It starts with the individual but extends to the environment and policy.

Tobacco Cessation and Weight Management

Smoking cessation is critical for cardiovascular health, but it can be accompanied by weight gain. The authors emphasize that tobacco cessation should still be a priority, and weight gain should be managed simultaneously through a healthy diet and physical activity.

Prudent Diet Pattern vs. Specific Dietary Components

The authors discuss the value of whole-diet patterns—such as the Mediterranean diet, the DASH (Dietary Approaches to Stop Hypertension) diet, and plant-based eating—rather than focusing obsessively on single nutrients. These patterns emphasize vegetables, fruits, whole grains, lean proteins, and healthy fats while limiting added sugars, salt, and refined carbohydrates.

Evidence for Dietary Quality

Not all calories are equal. Diets high in refined carbohydrates and added sugars are particularly linked to visceral fat, insulin resistance, and inflammation, even when total calories are similar. The glycemic index (GI) may be a useful tool: high-GI foods cause rapid blood sugar spikes, which can increase hunger and fat storage.

Physical Activity and Exercise Training

Regular physical activity is one of the most powerful tools. The authors recommend a combination of aerobic exercise (like walking, jogging, cycling) and resistance training. Exercise not only helps with weight maintenance but also improves cardiorespiratory fitness, which reduces cardiovascular risk even if the scale does not move dramatically. The goal may be expressed in metabolic equivalents (METs); improving from being unfit to fit is associated with major health benefits.

Reducing Sedentary Behavior

Beyond exercise, sitting less matters. Prolonged sedentary time is an independent risk factor for obesity and heart disease. Patients should aim to break up sitting time with short walks or standing throughout the day.

Community and Societal Action

Individual willpower is not enough. The authors advocate for community prevention strategies—such as improving walkability, creating safe recreational spaces, and implementing nutritional standards in schools—and for societal/authoritative policies, including taxes on sugar-sweetened beverages, clear food labeling, and restrictions on marketing unhealthy food to children.

Pharmacotherapy

For some patients, lifestyle changes are insufficient. The review briefly discusses anti-obesity medications. The authors note that pharmacotherapy should be considered in the context of a comprehensive weight-management program and used only under medical supervision. Weight-loss medications may be helpful for patients who are not achieving weight loss with lifestyle alone or who have obesity-related complications.

Bariatric Surgery

Bariatric surgery is the most effective treatment for severe obesity. It produces substantial and sustained weight loss, and it often dramatically improves or resolves type 2 diabetes, hypertension, sleep apnea, and heart failure risk. The authors note that surgery is an option for patients with Class III obesity or Class II obesity with significant comorbidities, but it requires lifelong follow-up and lifestyle adjustments.

The Role of Healthcare Providers and Health Promotion

The economic and public health burden of chronic diseases, including obesity, is enormous. The authors stress that obesity is one of the leading modifiable risk factors for chronic disease. In order to reverse the epidemic, they support a shift from treatment to primordial prevention—preventing risk factors from ever developing in the first place.

They introduce the concept of Healthy Living Medicine (HLM) and the Healthy Living Practitioner (HLP) as part of an evolving model for healthcare professionals. Rather than only prescribing medication, clinicians should be trained to counsel on nutrition, physical activity, sleep, and stress management. This requires changes in medical school curricula and continuing education.

The review also encourages healthcare providers to assess not just BMI, but also waist circumference, blood pressure, glucose, cholesterol, and fitness. It recommends that caregivers and health systems use every patient encounter as an opportunity to promote healthy living.

Limitations and Controversies

The authors acknowledge several unresolved areas. First, the causes of obesity remain highly complex and controversial, ranging from genetics to environment to psychological factors. Second, the MHO phenotype is not uniformly defined, making it difficult to know whether truly "healthy" obesity exists. Third, the obesity paradox is based on observational data, and the authors caution that it should not be used to discourage weight loss. Finally, while animal models provide insight into mechanisms like lipotoxicity, confirming those mechanisms in humans requires further research.

The review is not a clinical trial; it is a state-of-the-art synthesis of current evidence. As with any review, the conclusions are based on the literature available up to the time of publication (2018).

Practical Recommendations for Patients

Based on this review, here is what patients can do to pursue a healthy weight and protect their heart:

1. Know your numbers. Ask your doctor to measure not only your BMI but also your waist circumference, blood pressure, blood sugar, cholesterol, and if possible, your cardiorespiratory fitness.
2. Aim for a prudent diet pattern. Focus on vegetables, fruits, whole grains, legumes, nuts, fish, and healthy oils. Reduce refined carbohydrates, added sugars, and sugar-sweetened beverages.
3. Move more. Work toward at least 150 minutes per week of moderate-intensity aerobic activity, plus resistance training twice a week. Any increase in fitness helps, even if your weight changes slowly.
4. Break up sitting time. Stand up and move for a few minutes every hour. Use a step counter if it helps you stay accountable.
5. Prioritize sleep. Untreated sleep apnea can worsen both obesity and heart health. If you snore loudly or wake up gasping, ask your doctor for a sleep evaluation.
6. Ask about all treatment options. If lifestyle changes are not enough, ask your doctor whether anti-obesity medication or bariatric surgery is right for you. These are powerful tools when used correctly.
7. Advocate for healthy environments. Support policy changes that make healthy food and physical activity easier for everyone—because individual success is tied to community health.
8. Don't equate weight with worth. Weight stigma and emotional stress are real and can undermine progress. Seek supportive healthcare teams and address psychological well-being as part of your weight plan.

Frequently Asked Questions

How does excess weight harm the heart?

Excess weight increases total blood volume, making the heart pump more blood per minute. This causes the left ventricle to enlarge and thicken. Hormonal changes, including insulin resistance, inflammation, and activation of the renin-angiotensin system, also contribute. Over time, these changes can lead to heart failure, even in people without symptoms.

What is a healthy weight, and is BMI enough?

A healthy BMI is 18.5 to 24.9 kg/m², but waist circumference matters too. High waist-to-hip ratio or waist circumference increases risk at any BMI. For example, waist circumference above 40 inches in men or 34.6 inches in women signals increased chronic disease risk. Fitness also modifies risk, so BMI alone is not the whole story.

What is metabolically healthy obesity?

Metabolically healthy obesity means having a BMI of 30 or higher without hypertension, abnormal cholesterol, insulin resistance, or diabetes. Whether it is truly safe is controversial. The article says it may still carry excess cardiovascular risk compared to normal-weight metabolically healthy people. Fitness can modify risk, but caution is needed.

What is the obesity paradox?

The obesity paradox is an observation that in some people with established heart disease, those with overweight or obesity appear to survive longer than normal-weight patients. This does not mean obesity is protective. It may reflect greater metabolic reserve or frailty in normal-weight patients. Observational data like this should not discourage weight loss.

How are obesity and sleep apnea connected?

Obesity is the strongest risk factor for obstructive sleep apnea. Fat around the neck and central obesity narrow the airway and make it more collapsible. Sleep apnea prevalence is over 40% in overweight individuals and up to 98% in severe obesity. Weight loss is the most important effective component for reversing sleep apnea.

What treatment options are available for obesity?

Treatment starts with lifestyle: a prudent diet pattern, at least 150 minutes weekly of moderate aerobic activity, resistance training, and reducing sedentary time. Anti-obesity medications can help under medical supervision if lifestyle alone is insufficient. Bariatric surgery is the most effective treatment for severe obesity, improving or resolving diabetes, hypertension, and sleep apnea.

What practical steps can protect my heart if I have obesity?

Know your numbers: ask for BMI, waist circumference, blood pressure, blood sugar, cholesterol, and fitness. Focus on vegetables, fruits, whole grains, and fish while reducing added sugars. Move more, break up sitting time, prioritize sleep, ask about all treatment options, and advocate for community environments that support healthy choices.

Source Information

This patient-friendly article is based on peer-reviewed research published in the Journal of the American College of Cardiology:

Original Title: Healthy Weight and Obesity Prevention (JACC Health Promotion Series)
Authors: Carl J. Lavie, MD; Deepika Laddu, PhD; Ross Arena, PhD, PT; Francisco B. Ortega, PhD; Martin A. Alpert, MD; Robert F. Kushner, MD
Journal: Journal of the American College of Cardiology, Vol. 72, No. 23, 2018, pages 3027–3052
Reprint: This is a reprint of a previously published article: J Am Coll Cardiol 2018;72:1506–31.
DOI of original item: https://doi.org/10.1016/j.jacc.2018.08.1037
DOI of this reprint: https://doi.org/10.1016/j.jacc.2018.10.024

This patient-friendly article is based on peer-reviewed research. It is intended for educational purposes and does not replace individual medical advice.